A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC

Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC

NCT05244213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

NCT04426825 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC

NCT06300424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

NCT04501497 ·Status: COMPLETED

Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer

NCT05965102 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

NCT04294810 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]

NCT04059887 ·Status: COMPLETED ·Phase: PHASE4

Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLC

NCT06690541 ·Status: NOT_YET_RECRUITING

Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759

NCT03360929 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

NCT05896059 ·Status: RECRUITING ·Phase: PHASE2

AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC

NCT06196814 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

NCT04808050 ·Status: COMPLETED

A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection

NCT05120349 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT03922997 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer

NCT05241028 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer

NCT05284539 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer

NCT05492045 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).

NCT02088112 ·Status: COMPLETED ·Phase: PHASE1

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

NCT00600587 ·Status: COMPLETED ·Phase: PHASE2

Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer

NCT05991895 ·Status: RECRUITING

A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina

NCT03321695 ·Status: COMPLETED

AZD9291 First Time In Patients Ascending Dose Study

NCT01802632 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors

NCT06772610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)

NCT03416231 ·Status: UNKNOWN ·Phase: PHASE2

Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLC

NCT05215951 ·Status: TERMINATED ·Phase: PHASE2